The TrialNet team will be screening family members of people with type 1 diabetes at the University of Florida Clinical & Translational Research Building (CTRB) during the World Diabetes Awareness Month of November.
The Pathway to Prevention Study screens relatives for autoantibodies through a simple blood draw at no charge. Autoantibodies may appear years before the onset of type 1 diabetes, which help determine risk and eligibility to participate in a type 1 diabetes prevention trial or close monitoring.
Who Can Participate?
Individuals who are 1-45 years of age with a parent, child, brother or sister with Type 1 Diabetes or individuals who are 1-20 years of age with a niece, aunt, uncle, grandparent, half-sibling or cousin with Type 1 Diabetes may participate.